Complement activation, however, also has the potential to change the TME towards a tumor-supportive environment depending on a number of variables, including the tumor's cellular origin, its innate ability to produce autologous complement proteins, the makeup of the tumor microenvironment, and the degree of complement activation [73]. Here, VTN is linked to neoplasm.